Skip to content
IBEX

IBEX Ltd

IBEX Ltd Q4 FY2026 earnings call

September 10, 2026 · fiscal period ended 2026-06

EPS · actual vs est

$0.85 / $0.85Miss -0.4%

Revenue · actual vs est

$164.3M / $160.6MBeat +2.3%
Ask about this call

Summary

Generated 2026-09-10

Management highlights

  • Record Financial Performance: The company reported record full-year revenue of $644.1 million (15% organic growth) and achieved record adjusted EBITDA, EPS, operating cash flow, and free cash flow for fiscal 2026.
  • AI Agent Strategy (BPO 3.0): IBEX has successfully transitioned AI from a perceived threat to a primary growth driver through its strategic partnership with Sierra AI. The integrated solution delivers high resolution rates (>20-40%) and customer satisfaction scores (>4.7/5.0) comparable to or exceeding human agents.
  • Key AI Case Studies:
    • Philippine Airlines: Won proof of concept in Q4; launched full-scale deployment at start of FY2027 across three languages without cannibalizing existing human agent revenue.
    • BJ's Wholesale: A new trophy client win led by AI solutions, achieving >40% resolution rates; traditional human agent expansion anticipated in H1 FY2027.
    • Digital Acquisition: Leveraging AI agents to convert inbound IVR calls into sales opportunities for human agents, creating a virtuous cycle of marketing and revenue.
    • Luxury Activewear Brand: Signed long-term agreement within 30 days of introduction by Sierra AI, demonstrating rapid execution capabilities.
  • Client Retention and Wins: Added nine new trophy logos in Q4 (17 for the year). Client retention rates remained north of 99%. Net Promoter Score (NPS) is 71.
  • Operational Efficiency: Employee NPS improved from 77 to 82. The company continues to optimize its geographic mix, with offshore regions maintaining high margins while onshore grows in higher-margin verticals like health tech.
  • Market Differentiation: Management emphasizes that competitors are lagging in AI adoption, allowing IBEX to capture market share through superior operational performance and early AI integration.
View in transcript ↓

Segment performance

  • Health Tech: Q4 revenue was $29.4 million (42% YoY growth), representing 17.9% of total revenue. Full-year revenue reached $114 million (38% YoY growth). This segment significantly surpassed the internal goal of becoming a $100 million business.
  • Technology: Q4 revenue grew 27% year-over-year, increasing its contribution to 8.4% of total revenue.
  • Travel, Transportation, and Logistics: Q4 revenue grew 18% year-over-year, accounting for 14.5% of total revenue.
  • Retail and E-commerce: Q4 revenue grew 7% year-over-year, comprising 24.2% of total revenue.
  • Telecommunications: Revenue exposure decreased to 9.4% of total revenue (from 10.9% in the prior quarter) due to lower volume from legacy carriers.
  • Fintech: Revenue increased 3%, representing 9.7% of total revenue.
View in transcript ↓

Guidance

  • First Quarter FY2027 Revenue: Expected to be $168–$170 million, representing 11–12% growth.
  • First Quarter FY2027 Adjusted EBITDA: Expected to be $22–$23 million, representing 13–18% growth.
  • Full Year FY2027 Revenue: Projected at $700–$715 million, indicating 9–11% growth.
  • Full Year FY2027 Adjusted EBITDA: Projected at $90–$94 million, indicating 9–14% growth.
  • Capital Expenditures: Expected to range between $25–$30 million for FY2027.
  • Tax Rate: Normalized tax rate expected to be in the 20–22% range going forward.
View in transcript ↓

Risks

  • Margin Pressure in Q4: Adjusted EBITDA margin contracted slightly to 12.3% (from 13.9% in the prior year period) due to training expenses for new clients, temporary inefficiencies from transferring work from nearshore to offshore centers, and higher fuel prices affecting utility and transportation costs in offshore regions.
  • GAAP Net Income Decline: GAAP net income decreased to $8.7 million from $9.6 million in the prior year quarter, impacted by lease termination losses ($2 million), severance expenses, impairment losses, and higher fuel/utility costs.
  • Working Capital Usage: While operating cash flow hit a record $59 million, this was partially offset by higher use of working capital.
  • Execution Risks in AI Scaling: While AI traction is strong, management notes that scaling AI deployments requires continuous investment and successful integration to maintain the competitive moat against pure-play AI firms and traditional BPOs.
View in transcript ↓

Q&A highlights

Q: Analyst asked if AI is currently driving growth acceleration or if it remains a future factor, noting the irony of growth accelerating as AI fears mount. / A: CEO Bob Dechant explained that the Sierra AI partnership differentiates IBEX, moving it into a classification where it serves as both a human and AI partner. He emphasized that AI allows for rapid scaling (20-40% enterprise volume) compared to the slow hiring/training cycles of human agents, creating an immediate pathway to revenue and future-proofing the business against AI threats.

Q: Analyst questioned the sustainability of the lower-than-normal Q4 tax rate and how it should be modeled for the coming year. / A: CFO Taylor confirmed that the Q4 rate benefited from discrete items, including a favorable resolution of an uncertain tax position. For modeling purposes, management expects the normalized effective tax rate to return to a structural range of 20% to 22% going forward.

Q: Analyst requested detailed color on vertical growth trajectories for each key sector heading into Q1 FY2027, asking if growth is accelerating. / A: CEO highlighted strong pipelines in Health Tech (both major payers and specialty areas like non-emergency medical transport) and robust e-commerce wins driven by low-cost markets like Pakistan. In Travel, he cited the Philippine Airlines deal as evidence of winning market share via AI containment strategies. He stressed that IBEX is outperforming competitors who are not leaning into AI, allowing IBEX to lead in all verticals.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.85$0.85-0.4%$0.87
Revenue$164.3M$160.6M+2.3%$147.1M

Transcript

September 10, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.